Current Issue

Application of Quality Risk Management to Process Validation

Robert Dream, Managing Director, HDR Company LLC

A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization

Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...

Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...

Ping Wang, Director, Johnson & Johnson

Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics

Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...

Amsphere A3

JSR Life Sciences



Headline News

FDA grants Priority Review to uniQure’s Huntington’s disease gene therapy


Teva discontinues Phase II emrusolmin trial in multiple system atrophy after futility analysis


Impella registry analyses report lower mortality than CHIP-BCIS3 in high-risk PCI


Read All Headlines

Upcoming Webinars

View All Upcoming Webinars

Past Webinars

Handling mutagenic extractable and leachable compounds released from devices

Presented by Ron Brown, Toxicologist at Risk Science Consortium and Piet Christieans, PhD, Scientific Director at Nelson Labs
10th February 2022


Pharmaceutical Forensics for Safe Manufacturing and Supply

Presented by Ravi Kalyanaraman, Director at Bristol-Myers Squibb and Jeremy Peters, Scientist at Bristol-Myers Squibb and Dr. Robert Heintz, Senior Applications Specialist at Thermo Fisher Scientific
14th June 2019


Characterisation of Host-Cell Proteins using Mass Spectrometry Enables Effective Purification Optimisation

Presented by Dr Li Zang of Biogen
31st October 2017


View All Past Webinars

Featured Companies

 

View All Companies

© 2026 biopharma-asia.com. All rights reserved. Privacy Policy

Biopharma Asia